Devices › Device types
FDA product code NCF · class 1 · Ophthalmic
Aberrometer, ophthalmic: medical device reports filed with FDA
652 reports carry this product code, 2003–2026; 1 brands with a page.
- 652
- reports with this product code
- 0% of all MAUDE reports
- 46
- reports, 12 months to August 2026
- 39 in the 12 months before
- 47.4%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code NCF is FDA's classification for "Aberrometer, ophthalmic" (ophthalmic panel), a class 1 device. 652 medical device reports carry this product code, 0% of the MAUDE database, from July 2003 to August 2026.
46 reports arrived in the 12 months to August 2026, up 18% from 39 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (52.6%) and malfunction (47.4%). 1 brand name with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| ORA System with VerifEye Messaging | 438 | 26 | 0% | 46.6% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Alcon Research - Irvine Technology Center | 645 | 98.9% |
| Wavelight | 1 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Incorrect measurementthe device measured wrongly | 114 | 17.5% |
| Incorrect, inadequate or imprecise result or readings | 106 | 16.3% |
| Loose or intermittent connection | 79 | 12.1% |
| Device operates differently than expectedthe device behaved unexpectedly | 55 | 8.4% |
| Insufficient device problem information | 32 | 4.9% |
| Unexpected therapeutic results | 17 | 2.6% |
| Improper or incorrect procedure or method | 12 | 1.8% |
| Failure to align | 11 | 1.7% |
| Application program problem: power calculation error | 6 | 0.9% |
| Power problem | 6 | 0.9% |
| Device displays incorrect message | 5 | 0.8% |
| False reading from device non-compliance | 5 | 0.8% |
| Malposition of device | 5 | 0.8% |
| Overcorrection | 5 | 0.8% |
| Therapeutic or diagnostic output failure | 5 | 0.8% |
| Improper device output | 4 | 0.6% |
| Output problem | 4 | 0.6% |
| Patient-device incompatibilitythe device did not suit the patient | 4 | 0.6% |
| Breakthe device broke | 3 | 0.5% |
| Component missing | 3 | 0.5% |
Questions about aberrometer, ophthalmic reports
What is product code NCF?
FDA's classification code for "Aberrometer, ophthalmic", class 1, reviewed by the ophthalmic panel. Every device report carries the product code of the device involved.
How many reports carry this code?
652 reports through August 2026, 46 of them in the latest 12 months.
Which brands appear most often?
ORA System with VerifEye Messaging (438). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.